Nuveen »

Eikon Therapeutics shares owned by Nuveen

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $378k 29k 13.05

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
T. Rowe Price Associates
Vanguard Capital Management
EcoR1 Capital
Alliancebernstein
Geode Capital Management
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board

View all funds holding Eikon Therapeutics